ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	26/235	191/7206	4.15107709979e-10
ko04380	Osteoclast differentiation	20/235	134/7206	9.76237165929e-09
ko04660	T cell receptor signaling pathway	18/235	124/7206	8.57898802971e-08
ko04672	Intestinal immune network for IgA production	10/235	37/7206	1.80534510408e-07
ko05131	Shigellosis	13/235	82/7206	2.04629894611e-06
ko05323	Rheumatoid arthritis	13/235	89/7206	5.26519735067e-06
ko05152	Tuberculosis	19/235	187/7206	9.71093896095e-06
ko04064	NF-kappa B signaling pathway	13/235	96/7206	1.23412014939e-05
ko04621	NOD-like receptor signaling pathway	17/235	157/7206	1.25147273975e-05
ko04630	Jak-STAT signaling pathway	15/235	132/7206	2.30997806293e-05
ko05164	Influenza A	17/235	167/7206	2.82511387628e-05
ko04668	TNF signaling pathway	14/235	120/7206	3.22726096804e-05
ko05145	Toxoplasmosis	14/235	126/7206	5.58304500146e-05
ko04658	Th1 and Th2 cell differentiation	12/235	96/7206	6.02688466557e-05
ko04650	Natural killer cell mediated cytotoxicity	12/235	97/7206	6.68228837322e-05
ko05132	Salmonella infection	12/235	98/7206	7.3983339741e-05
ko04062	Chemokine signaling pathway	18/235	201/7206	9.06842510052e-05
ko05133	Pertussis	11/235	87/7206	0.00011028866825
ko05140	Leishmaniasis	10/235	75/7206	0.000144675176096
ko04622	RIG-I-like receptor signaling pathway	9/235	62/7206	0.000160651447906
ko04620	Toll-like receptor signaling pathway	11/235	100/7206	0.00038424433853
ko05321	Inflammatory bowel disease (IBD)	8/235	56/7206	0.000416734226186
ko05162	Measles	12/235	120/7206	0.000509768759732
ko04659	Th17 cell differentiation	11/235	106/7206	0.000635215194227
ko04217	Necroptosis	15/235	178/7206	0.000671587544085
ko05150	Staphylococcus aureus infection	6/235	36/7206	0.000966606305953
ko04670	Leukocyte transendothelial migration	13/235	151/7206	0.00125100407126
ko04933	AGE-RAGE signaling pathway in diabetic complications	12/235	135/7206	0.001453759108
ko05161	Hepatitis B	14/235	173/7206	0.00149549785285
ko05168	Herpes simplex infection	14/235	182/7206	0.00241173089774
ko05340	Primary immunodeficiency	5/235	30/7206	0.00258401600321
ko05144	Malaria	6/235	45/7206	0.00316598618124
ko05142	Chagas disease (American trypanosomiasis)	11/235	130/7206	0.00334839991796
ko04610	Complement and coagulation cascades	8/235	79/7206	0.00402637372129
ko05034	Alcoholism	1/235	238/7206	0.00495565209525
ko04917	Prolactin signaling pathway	8/235	87/7206	0.00722246756818
ko04210	Apoptosis	13/235	180/7206	0.00819874708352
ko05120	Epithelial cell signaling in Helicobacter pylori infection	8/235	92/7206	0.0100179554004
ko04623	Cytosolic DNA-sensing pathway	5/235	41/7206	0.0101666518837
ko05016	Huntington's disease	1/235	215/7206	0.0104489445123
ko04611	Platelet activation	12/235	163/7206	0.0110717204538
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/235	191/7206	0.0110721818363
ko00051	Fructose and mannose metabolism	5/235	42/7206	0.0112416462095
ko04664	Fc epsilon RI signaling pathway	7/235	77/7206	0.0124198996339
ko05166	HTLV-I infection	17/235	292/7206	0.0177098605197
ko04666	Fc gamma R-mediated phagocytosis	9/235	122/7206	0.0179011908556
ko04657	IL-17 signaling pathway	7/235	87/7206	0.0229957517458
ko04662	B cell receptor signaling pathway	7/235	88/7206	0.0243152183596
ko00120	Primary bile acid biosynthesis	3/235	20/7206	0.0259076641098
ko04728	Dopaminergic synapse	1/235	185/7206	0.0324108507133
ko00966	Glucosinolate biosynthesis	1/235	1/7206	0.0326117124619
ko05160	Hepatitis C	10/235	153/7206	0.0335571406285
ko05130	Pathogenic Escherichia coli infection	6/235	77/7206	0.0391200075728
ko05100	Bacterial invasion of epithelial cells	7/235	99/7206	0.0423709402776
ko00140	Steroid hormone biosynthesis	4/235	41/7206	0.0435100906065
ko04723	Retrograde endocannabinoid signaling	1/235	175/7206	0.047453927307